big data in biomedicine: where is the nih headed

45
Big Data in Biomedicine: Where is the NIH Headed? Philip E. Bourne Ph.D., FACMI Associate Director for Data Science National Institutes of Health [email protected] http://www.slideshare.net/pebourne

Upload: philip-bourne

Post on 23-Jan-2017

951 views

Category:

Education


0 download

TRANSCRIPT

Page 1: Big Data in Biomedicine: Where is the NIH Headed

Big Data  in Biomedicine:Where is the NIH Headed?

Philip E. Bourne Ph.D., FACMIAssociate Director for Data Science

National Institutes of [email protected]

http://www.slideshare.net/pebourne

Page 2: Big Data in Biomedicine: Where is the NIH Headed

Agenda

What are the implications of Big Data on biomedical research and healthcare?

Use cases

What actions are we taking?

Page 3: Big Data in Biomedicine: Where is the NIH Headed

Implications:Quantifying the Problem

Big Data– Total data from NIH-funded research currently estimated

at 650 PB*– 20 PB of that is in NCBI/NLM (3%) and it is expected to

grow by 10 PB this year Dark Data

– Only 12% of data described in published papers is in recognized archives – 88% is dark data^

Cost– 2007-2014: NIH spent ~$1.2Bn extramurally on

maintaining data archives

* In 2012 Library of Congress was 3 PB^ http://www.ncbi.nlm.nih.gov/pubmed/26207759

Page 4: Big Data in Biomedicine: Where is the NIH Headed

Big Data in Biomedical Research & Healthcare. We are assuming…

This speaks to something more fundamental that more data …

It speaks to new methodologies, new skills, new emphasis, new cultures, new modes of discovery …

Page 5: Big Data in Biomedicine: Where is the NIH Headed

It Follows …

We are entering a period of disruption in biomedical research and we should all be thinking about what this means

http://i1.wp.com/chisconsult.com/wp-content/uploads/2013/05/disruption-is-a-process.jpg http://cdn2.hubspot.net/hubfs/418817/disruption1.jpg

Page 6: Big Data in Biomedicine: Where is the NIH Headed

We are at a Point of Deception …

Evidence:– Google car– 3D printers– Waze– Robotics– Sensors

From: The Second Machine Age: Work, Progress, and Prosperity in a Time of Brilliant Technologies by Erik Brynjolfsson & Andrew McAfee

Page 7: Big Data in Biomedicine: Where is the NIH Headed

Disruption: Example - Photography

DigitizationDeception

Disruption

Demonetization

Dematerialization

Democratization

Time

Vol

ume,

Vel

ocity

, Var

iety

Digital camera invented byKodak but shelved

Megapixels & quality improve slowly; Kodak slow to react

Film market collapses;Kodak goes bankrupt

Phones replacecameras

Instagram,Flickr become thevalue proposition

Digital media becomes bona fide form of communication

Page 8: Big Data in Biomedicine: Where is the NIH Headed

Disruption: Biomedical Research

Digitization of Basic & Clinical Research & EHR’s

Deception

We Are Here

Disruption

Demonetization

Dematerialization

Democratization

Open science

Patient centered health care

Page 9: Big Data in Biomedicine: Where is the NIH Headed

Implications: Sustainability

Source Michael Bell http://homepages.cs.ncl.ac.uk/m.j.bell1/blog/?p=830

Page 10: Big Data in Biomedicine: Where is the NIH Headed

Implications:Reproducibility

Changing Value of Scholarship (?)

Page 11: Big Data in Biomedicine: Where is the NIH Headed

“And that’s why we’re here today. Because something called precision medicine … gives us one of the greatest opportunities for new medical breakthroughs that we have ever seen.”

President Barack ObamaJanuary 30, 2015

Implications – New Science

Page 12: Big Data in Biomedicine: Where is the NIH Headed

Precision Medicine Initiative

National Research Cohort – >1 million U.S. volunteers– Numerous existing cohorts (many funded by NIH)– New volunteers

Participants will be centrally involved in design and implementation of the cohort

They will be able to share genomic data, lifestyle information, biological samples – all linked to their electronic health records

Page 13: Big Data in Biomedicine: Where is the NIH Headed

What Are Some General Implications of Such a Future?

Open collaborative science becomes of increasing importance nationally and internationally

Global cooperation between funders will be needed to sustain the emergent digital enterprise

The value of data and associated analytics becomes of increasing value to scholarship

Opportunities exist to improve the efficiency of the research enterprise and hence fund more research

Current training content and modalities will not match supply to demand

Balancing accessibility vs security becomes more important yet more complex

Page 14: Big Data in Biomedicine: Where is the NIH Headed

Agenda

What are the implications of Big Data on biomedical research and healthcare?

Use cases

What actions are we taking?

Page 15: Big Data in Biomedicine: Where is the NIH Headed

Use Case:

Aggregate integrated data offers the potential for new insights into rare

diseases …

As we get more precise every disease becomes a rare disease

Page 16: Big Data in Biomedicine: Where is the NIH Headed

Diffuse Intrinsic Pontine Gliomas (DIPG): In need of a new data-driven approach

• Occur 1:100,000 individuals

• Peak incidence 6-8 years of age

• Median survival 9-12 months

• Surgery is not an option

• Chemotherapy ineffective and radiotherapy only transitive

From Adam Resnick

Page 17: Big Data in Biomedicine: Where is the NIH Headed

Timeline of Genomic Studies in DIPG

• Landmark studies identify histone mutations as recurrent driver mutations in DIPG ~2012

• Almost 3 years later, in largely the same datasets, but partially expanded, the same two groups and 2 others identify ACVR1 mutations as a secondary, co-ocurring mutation

From Adam Resnick

Page 18: Big Data in Biomedicine: Where is the NIH Headed

Hypothesis: The Commons would have revealed ACVR1

• ACVR1 is a targetable kinase • Inhibition of ACVR1 inhibited tumor progression in vitro

• ~300 DIPG patients a year

• ~60 are predicted to have ACVR1

• If large scale data sets were only integrated with TCGA and/or rare disease data in 2012, ACVR1 mutations would have been identified

• 60 patients/year X 3 years = 180 children’s lives (who likely succumbed to the disease during that time) could have been impacted if only data were FAIR

From Adam Resnick

Page 19: Big Data in Biomedicine: Where is the NIH Headed

Agenda

What are the implications of Big Data on biomedical research and healthcare?

Use cases

What actions are we taking?

Page 20: Big Data in Biomedicine: Where is the NIH Headed

The Commons – The Internet of Data

Findable Accessible Interoperable Reusable

* http://www.ncbi.nlm.nih.gov/pubmed/26978244

The Commons offers a path forward to integrate discreet cloud-based initiatives using BD2K developments to make data FAIR*

The internet started as discreet networks that merged - the same could happen with data

Page 21: Big Data in Biomedicine: Where is the NIH Headed

Examples of Commons Based Initiatives

5 PB

40TB AWS

Page 22: Big Data in Biomedicine: Where is the NIH Headed

Shared Research ObjectsNCBI Intramural Hybrid Extramural

NCBI/NLM Existing Coordinating CentersCIT IC’s

Step 1: Data & Analytics Moved to the Commons

Moved as Commons compliant shared research objects, including:– Identifiers– Minimal metadata standards

CF

Page 23: Big Data in Biomedicine: Where is the NIH Headed

BD2K is Providing Those Metadata Standards

Page 24: Big Data in Biomedicine: Where is the NIH Headed

Services: APIs, Containers, Indexing,

Software: Services & Tools

scientific analysis tools/workflows

App store/User Interface

Step 2: Layers of Software & Services Added

Shared Research ObjectsNCBI Intramural Hybrid Extramural

NCBI/NLM Existing Coordinating CentersCIT IC’sCF

Page 25: Big Data in Biomedicine: Where is the NIH Headed

DataMed is a “Find” Service Developed by BD2K

Page 26: Big Data in Biomedicine: Where is the NIH Headed

Services: APIs, Containers, Indexing,

Software: Services & Tools

scientific analysis tools/workflows

App store/User Interface

Step 3: Commons Content Shared While Maintaining Autonomous Views

IC IC IC CF

Shared Research ObjectsNCBI Intramural Hybrid Extramural

NCBI/NLM Existing Coordinating CentersCIT IC’sCF

Page 27: Big Data in Biomedicine: Where is the NIH Headed

BD2K Commons Pilot Timeline

Project Year 1FY 2015Oct 2015 – Sep 2016

Project Year 2FY 2016Oct 2016 – Sep 2017

Project Year 3FY 2017Oct 2017 – Sep 2018

Step 0 Step 1 Step 2 Step 3

Step 0: Initiation•Finalize conformance requirements•Arrange initial providers

Step 1: ~5 Initial Projects including Common Fund We Are Here

Step 2: ~50 projects

Step 3: Evaluation & Next Steps

Page 28: Big Data in Biomedicine: Where is the NIH Headed

Other Use Cases:Comorbidity Network for 6.2M Danes

Over 14.9 Years

Jensen et al 2014 Nat Comm 5:4022

Page 29: Big Data in Biomedicine: Where is the NIH Headed

EHR-basedphenotyping

neuroimage-basedphenotyping

transcriptome-basedphenotyping

epigenome-basedphenotyping

phenotype models forbreast cancer screening

stochasticmodeling

low-dimensionalrepresentations

data management

value of information

Pro

ject

s

Labs

The Center for Predictive Computational Phenotyping

Page 30: Big Data in Biomedicine: Where is the NIH Headed

EHR-based phenotyping

timenow

prospective phenotyping: predict a phenotype of interest before it is exhibited

retrospective phenotyping: identify subjects who have exhibited a phenotype of interest (i.e. identify cases and controls)

?

genotypedemographics

events in EHR (diagnoses, procedures, medications, labs, etc.)

Page 31: Big Data in Biomedicine: Where is the NIH Headed

We can predict thousands of diagnoses months in advance of

being recorded in an EHR

• ~ 1.5 million subjects from Marshfield Clinic• models learned for all ICD-9 codes (~3500) for which 500 cases and

controls identified

Page 32: Big Data in Biomedicine: Where is the NIH Headed
Page 33: Big Data in Biomedicine: Where is the NIH Headed
Page 34: Big Data in Biomedicine: Where is the NIH Headed
Page 35: Big Data in Biomedicine: Where is the NIH Headed
Page 36: Big Data in Biomedicine: Where is the NIH Headed
Page 37: Big Data in Biomedicine: Where is the NIH Headed
Page 38: Big Data in Biomedicine: Where is the NIH Headed

Mobile Sensor Data-to-Knowledge (MD2K)

Mob

ile S

enso

rs

Smartwatch Chestbands Smart Eyeglasses

Exp

osur

esB

ehav

iors

Out

com

es

Page 39: Big Data in Biomedicine: Where is the NIH Headed

Detecting First Lapses in Smoking Cessation

Modeling Challenges1. Ephemeral (very short duration)

– 3~4 sec for each puff– 10,000 breaths in 10 hours– 2,000 hand to mouth gestures– But, only 6~7 positive instances– Need high recall & low false alarm

2. Numerous confounders– Eating, drinking, yawning

Wide person & situation variability

http

s://w

ww

.pin

tere

st.c

om/p

in/

5267

1011

8890

7120

75/

Saleheen, et. al., ACM UbiComp 2015

Key Observations• First lapse consists of 7 (vs. 15) puffs• Only 20 (out of 28) reported lapse• Inaccuracy of self-reported lapse

– 12 min before to 41 min after lapse– Recall inaccuracy even higher

Main Results• Applied on smoking cessation data

from 61 smokers• Detected 28 (out of 32) first lapses• False alarm rate of 1/6 per day

Page 40: Big Data in Biomedicine: Where is the NIH Headed

Goal: To strengthen the ability of a diverse biomedical workforce to develop and benefit from data science

Page 41: Big Data in Biomedicine: Where is the NIH Headed

Where We Need Help

Indexing – structured (eg metadata, schema.org) vs unstructured

Machine learning Compression Visualization Security/Privacy of human subjects data Effective use of cloud technologies Platforms vs pipes

Your ideas here ….

Page 42: Big Data in Biomedicine: Where is the NIH Headed

Summary

Digital Big Data offers unprecedented opportunities to improve health

NIH is trying to initiate a significant change in how we manage and use data to realize the goal of improved health

Workforce training is part of that change We need your help

Page 43: Big Data in Biomedicine: Where is the NIH Headed

I not only use all the brains I have, but all I can borrow.

– Woodrow Wilson

Page 44: Big Data in Biomedicine: Where is the NIH Headed

ADDS Team

BD2K Representatives

Page 45: Big Data in Biomedicine: Where is the NIH Headed

NIHNIH……

Turning Discovery Into HealthTurning Discovery Into Health

[email protected]://datascience.nih.gov/

http://www.ncbi.nlm.nih.gov/research/staff/bourne/